Analyzing the Latest from Phase III IPF Clinical Trials

Time: 8:40 am
day: Day Two


  • Understanding the likely next therapies to hit the market
  • Accentuating the lessons learned from the trials and what to consider for the future
  • Considering how mechanism of action may translate into efficacy
  • Understanding the clinical trial endpoints used